- Home
- SLS vs PPLI Comparison
SLS vs PPLI Comparison
Compare SLS & PPLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLS | PPLI |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.9B |
| IPO Year | 2007 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SLS | PPLI |
|---|---|---|
| Price | $11.62 | $37.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 6.9M | 843.8K |
| Earning Date | 05-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | 50.00 | ★ 79.97 |
| EPS | N/A | ★ 5.65 |
| Revenue | N/A | ★ $4,365,235,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $110.98 | N/A |
| P/E Ratio | ★ N/A | $6.68 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.39 | $37.36 |
| 52 Week High | $15.88 | $48.32 |
Technical Indicators
Market Signals| Indicator | SLS | PPLI |
|---|---|---|
| Relative Strength Index (RSI) | 52.10 | 34.22 |
| Support Level | $12.64 | N/A |
| Resistance Level | $15.77 | $40.14 |
| Average True Range (ATR) | 1.12 | 0.94 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 29.70 | 1.74 |
Price Performance
Historical ComparisonAbout SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About PPLI People Incorporated Common Stock
People Inc is a media and publishing business that operates a portfolio of brands, including PEOPLE, Food & Wine, Travel + Leisure, InStyle, Better Homes & Gardens, and Southern Living. The company also holds a minority equity stake in MGM Resorts International.